Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
4SC AG
Pharmaceutical company receives financing through technology funds
August 10th, 2005
4SC AG announced the successful completion of its fourth round of financing. The KfW Mittelstandsbank and Bayern Kapital (Bavarian Venture Capital Company) participated in the second closing in June so that the amount could be achieved in full. The first capital increase took place in December 2004 with investments from Deutsche Venture Capital Gesellschaft (DVC), 3i, BioM and Mulligan BioCapital. The total volume of the financing round amounts to EUR 6.5 million. During the start-up phase and the initial financing rounds, Bayern Kaptial and tbg (which has since been incorporated into the KfW Mittelstandsbank after its fusion with the KfW...
Source: Biotech Week (2005-08-10)
|
